| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |